These findings provide further insights into the mechanisms by which endocannabinoids influence feeding behavior and metabolic health, highlighting the potential for targeted therapies that modulate CB1 signaling to manage obesity. This evidence concerns the gene CNR1 and obesity due to melanocortin 4 receptor deficiency.